Jacquet Dominates Rune in Tokyo Opener as Dane's Return to Competition Ends Quickly

Kyrian Jacquet defeated Holger Rune 6-3, 6-1 in the first round of the Tokyo tournament, with the Frenchman winning all 19 first-serve points and never allowing a break point opportunity. Rune's return to the ATP Tour after an 11-month absence due to an Achilles tendon injury lasted only one match, though the Dane had shown promise in Davis Cup play the previous week. Jacquet, ranked No. 86, advances to face No. 19 Luciano Darderi in the next round.
Jacquet's performance was particularly impressive given his modest first-serve percentage of 43 percent. Despite getting his first serve in play less than half the time, he proved nearly untouchable on those occasions, converting every point when his initial delivery landed. This efficiency allowed him to control rallies and dictate terms throughout the match, breaking Rune's serve four times while protecting his own service games without difficulty.
Rune's injury layoff represents a significant challenge for his career trajectory. The 11-month absence from competition follows his previous success at this tournament, where he had reached the semifinals two years prior. His Davis Cup performances the week before suggested he was regaining match fitness, making this opening-round loss to a lower-ranked opponent a sobering reminder of the physical and competitive demands of returning to professional tennis after extended recovery.
This match outcome could influence perceptions about injury comebacks on professional tennis tours. Rune's rapid elimination may raise questions about appropriate return-to-competition timelines and whether players benefit from additional preparation matches before tournament play. The result may also affect sponsorship decisions and fan confidence in recovering athletes, though it represents just one match in what could be a lengthy rehabilitation process. For Jacquet, the victory may enhance his standing among tour sponsors and ranking points crucial for career advancement.